BioVie
BIVI
56 hedge funds and large institutions have $5.95M invested in BioVie in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
6% more funds holding
Funds holding: 53 → 56 (+3)
0.01% less ownership
Funds ownership: 0.05% → 0.05% (-0.01%)
28% less capital invested
Capital invested by funds: $8.29M → $5.95M (-$2.34M)
72% less call options, than puts
Call options by funds: $750K | Put options by funds: $2.66M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
+$362K |
| 2 |
Cerity Partners
New York
|
+$139K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$82.1K |
| 4 |
Morgan Stanley
New York
|
+$72.3K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$69.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.08M |
| 2 |
WG
Winton Group
London,
United Kingdom
|
-$128K |
| 3 |
GC
Garde Capital
Seattle,
Washington
|
-$104K |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$96.1K |
| 5 |
BlackRock
New York
|
-$81.7K |
BIVI Hedge Fund Activity: Q3 2023 in Review
56 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q3 2023, worth a combined $5.95M — down 28% from $8.29M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BIVI positions and 7 closed out — a net gain of 5 holders — while 16 added to existing stakes and 14 trimmed.
The largest buyer was Moore Capital Management, opening a new position worth an estimated $362K. The largest seller was Millennium Management, cutting an estimated $1.08M.
- 56 institutional investors held BioVie (BIVI) as of Q3 2023, up from 53 in Q2 2023.
- Funds reported $5.95M of BioVie stock for Q3 2023, down 28% quarter-over-quarter.
- 12 funds opened new BioVie positions in Q3 2023 and 7 closed out, a net change of +5 holders.
- The largest BioVie buyer in Q3 2023 was Moore Capital Management, an estimated $362K added.
- The largest BioVie seller in Q3 2023 was Millennium Management, an estimated $1.08M sold.
Based on aggregated 13F filings for Q3 2023.